120 related articles for article (PubMed ID: 766339)
1. The influence of age and sex on the incidence of the 'flu' syndrome and rifampicin-dependent antibodies in patients on intermittent rifampicin for tuberculosis.
Tubercle; 1975 Sep; 56(3):173-8. PubMed ID: 766339
[No Abstract] [Full Text] [Related]
2. A controlled trial of daily and intermittent rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis: results up to 30 months.
Tubercle; 1975 Sep; 56(3):179-89. PubMed ID: 766340
[TBL] [Abstract][Full Text] [Related]
3. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
Eule H; Werner E; Winsel K; Iwainsky H
Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
[No Abstract] [Full Text] [Related]
4. Side effects observed during intermittent rifampicin therapy.
Stradling P
Scand J Respir Dis Suppl; 1973; 84():129-31. PubMed ID: 4522066
[No Abstract] [Full Text] [Related]
5. Serum rifampicin concentration related to dose size and to the incidence of the 'flu' syndrome during intermittent rifampicin administration.
Dickinson JM; Mitchison DA; Lee SK; Ong YY; O'Mahoney MG; Girling DJ; Nunn AJ
J Antimicrob Chemother; 1977 Sep; 3(5):445-52. PubMed ID: 903325
[No Abstract] [Full Text] [Related]
6. Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. The results up to 30 months.
Am Rev Respir Dis; 1977 Nov; 116(5):807-20. PubMed ID: 411405
[No Abstract] [Full Text] [Related]
7. Proceedings of the Workshop on Intermittent Drug Therapy and Immunological Implications in Antituberculous Treatment with Rifampicin. Oct. 2-3, 1972 Stockholm. Organized by The Department of Thoracic Medicine, Karolinska Sjukhuset.
Scand J Respir Dis Suppl; 1973; 84():1-193. PubMed ID: 4593267
[No Abstract] [Full Text] [Related]
8. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
Guerra Sanz FJ
Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
[No Abstract] [Full Text] [Related]
9. Intermittent rifampicin treatment of tuberculosis.
Riska N; Mattson K
Scand J Respir Dis Suppl; 1973; 84():140-4. PubMed ID: 4522069
[No Abstract] [Full Text] [Related]
10. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.
Lancet; 1975 Dec; 2(7945):1105-9. PubMed ID: 53598
[TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of side effects on intermittent rifampicin regimen.
Zierski M
Scand J Respir Dis Suppl; 1973; 84():166-73. PubMed ID: 4522072
[No Abstract] [Full Text] [Related]
12. 'Flu' syndrome on once monthly rifampicin: a case report.
Vaz M; Jacob AJ; Rajendran A
Lepr Rev; 1989 Dec; 60(4):300-2. PubMed ID: 2607880
[TBL] [Abstract][Full Text] [Related]
13. 'Flu' syndrome on once monthly rifampicin.
Patki AH; Jadhav VH; Mehta JM
Indian J Lepr; 1988 Jan; 60(1):84-6. PubMed ID: 3204279
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects and side effects of rifampicin administered daily or twice-weekly.
Gomi J; Aoyagi T
Scand J Respir Dis Suppl; 1973; 84():145-52. PubMed ID: 4522070
[No Abstract] [Full Text] [Related]
15. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
Nitti V
Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
[No Abstract] [Full Text] [Related]
16. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
Girling DJ
Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
[No Abstract] [Full Text] [Related]
17. [Systemic collateral effects of intermittent antituberculous treatments with rifampicin].
Decroix G; Pujet JC
Rev Tuberc Pneumol (Paris); 1971 Nov; 35(7):733-43. PubMed ID: 5151216
[No Abstract] [Full Text] [Related]
18. Relationship between rifampicin-dependent antibody scores, serum rifampicin concentrations and symptoms in patients with adverse reactions to intermittent rifampicin treatment.
O'Mahony MG; Kar CW
Clin Allergy; 1973 Dec; 3(4):353-62. PubMed ID: 4784489
[No Abstract] [Full Text] [Related]
19. [Controlled comparison of daily and intermittent treatment regimens with rifampicin].
Yamamoto K
Bull Int Union Tuberc; 1974; 49(1):442-6. PubMed ID: 4619565
[No Abstract] [Full Text] [Related]
20. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions.
Girling DJ
Scand J Respir Dis Suppl; 1973; 84():119-24. PubMed ID: 4522064
[No Abstract] [Full Text] [Related]
[Next] [New Search]
